The Future of Clinical Trials is Decentralized’: Scott Stout, CEO of MedVector The Silicon Review

In the current clinical trial marketplace, patients must travel to clinical trial sites to access advanced medicine. The problem is, most sites are not near the patients… This creates challenges for doctor/patient awareness, demographic imbalances, and geographic constraints. Further, while treating physicians and specialists believe in clinical trials, they don’t refer their patients to them.…

5 Best Health Tech Companies to Watch 2021

Company Management Description Lumeon www.lumeon.com Robbie Hughes, Founder & CEO Health systems use Lumeon’s digital health platform to transform their care delivery processes into seamlessly orchestrated, personalized, virtualized care centered on each patient’s needs. With Lumeon, care delivery becomes frictionless, efficient, and effective, ensuring the best standard of safe care is delivered every time. eHealth…

MedVector Unveils Prime-Control Technology to Expand Subject Enrollment in Clinical Trials

MedVector introduces its Prime-Controltm Technology to provide contract research organizations and pharmaceutical sponsors with access to subjects for new clinical trials.  FREMONT, CA: MedVector has begun a nationwide rollout of its Prime-Controltm Technology, which will provide contract research organizations (CROs) and pharmaceutical sponsors with access to numerous patients without the requirement of new clinical trial sites.…

MedVector Expands Clinical Trials – Huxley Morton Podcast James Fowl presents Scott Stout Co-Founder/CEO of MedVector

Listen to CEO and Co-Founder, Scott Stout on The Huxley Morton Podcast – Series 2, Episode 8. Apple Podcast This week we hear from Scott Stout Co-founder and CEO of MedVector, a company that is streamlining the Clinical trial Industry. Providing pharmaceutical & Biotech companies, CRO’s and research institutes a global patient network, which enables…